Literature DB >> 18086781

Inherited predisposition of lung cancer: a hierarchical modeling approach to DNA repair and cell cycle control pathways.

Rayjean J Hung1, Meili Baragatti, Duncan Thomas, James McKay, Neonila Szeszenia-Dabrowska, David Zaridze, Jolanta Lissowska, Peter Rudnai, Eleonora Fabianova, Dana Mates, Lenka Foretova, Vladimir Janout, Vladimir Bencko, Amelie Chabrier, Norman Moullan, Federico Canzian, Janet Hall, Paolo Boffetta, Paul Brennan.   

Abstract

The DNA repair systems maintain the integrity of the human genome and cell cycle checkpoints are a critical component of the cellular response to DNA damage. We hypothesized that genetic variants in DNA repair and cell cycle control pathways will influence the predisposition to lung cancer, and studied 27 variants in 17 DNA repair enzymes and 10 variants in eight cell cycle control genes in 1,604 lung cancer patients and 2,053 controls. To improve the estimation of risks for specific variants, we applied a Bayesian approach in which we allowed the prior knowledge regarding the evolutionary biology and physicochemical properties of the variant to be incorporated into the hierarchical model. Based on the estimation from the hierarchical modeling, subjects who carried OGG1 326C/326C homozygotes, MGMT 143V or 178R, and CHEK2 157I had an odds ratio of lung cancer equal to 1.45 [95% confidence interval (95% CI), 1.05-2.00], 1.18 (95% CI, 1.01-1.40), and 1.58 (95% CI, 1.14-2.17). The association of CHEK2 157I seems to be overestimated in the conventional analysis. Nevertheless, this association seems to be robust in the hierarchical modeling. None of the pathways seem to have a prominent effect. In general, our study supports the notion that sequence variation may explain at least some of the variation of inherited susceptibility. In particular, further investigation of OGG1, MGMT, and CHEK2 focusing on the genetic regions where the present markers are located or the haplotype blocks tightly linked with these markers might be warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086781     DOI: 10.1158/1055-9965.EPI-07-0494

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  27 in total

1.  Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers.

Authors:  Lori C Sakoda; Melissa M Loomis; Jennifer A Doherty; Liberto Julianto; Matt J Barnett; Marian L Neuhouser; Mark D Thornquist; Noel S Weiss; Gary E Goodman; Chu Chen
Journal:  Int J Mol Epidemiol Genet       Date:  2012-02-05

2.  Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia.

Authors:  Darren R Brenner; Christopher I Amos; Yonathan Brhane; Maria N Timofeeva; Neil Caporaso; Yufei Wang; David C Christiani; Heike Bickeböller; Ping Yang; Demetrius Albanes; Victoria L Stevens; Susan Gapstur; James McKay; Paolo Boffetta; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Hans E Krokan; Frank Skorpen; Maiken E Gabrielsen; Lars Vatten; Inger Njølstad; Chu Chen; Gary Goodman; Mark Lathrop; Tõnu Vooder; Kristjan Välk; Mari Nelis; Andres Metspalu; Peter Broderick; Timothy Eisen; Xifeng Wu; Di Zhang; Wei Chen; Margaret R Spitz; Yongyue Wei; Li Su; Dong Xie; Jun She; Keitaro Matsuo; Fumihiko Matsuda; Hidemi Ito; Angela Risch; Joachim Heinrich; Albert Rosenberger; Thomas Muley; Hendrik Dienemann; John K Field; Olaide Raji; Ying Chen; John Gosney; Triantafillos Liloglou; Michael P A Davies; Michael Marcus; John McLaughlin; Irene Orlow; Younghun Han; Yafang Li; Xuchen Zong; Mattias Johansson; Geoffrey Liu; Shelley S Tworoger; Loic Le Marchand; Brian E Henderson; Lynne R Wilkens; Juncheng Dai; Hongbing Shen; Richard S Houlston; Maria T Landi; Paul Brennan; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2015-09-10       Impact factor: 4.944

3.  MGMT Leu84Phe gene polymorphism and lung cancer risk: a meta-analysis.

Authors:  Zhi-xiong Qiu; Fei Xue; Xuan-feng Shi; Xiao He; Hui-ni Ma; Lan Chen; Pin-zhong Chen
Journal:  Tumour Biol       Date:  2014-01-05

4.  CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer.

Authors:  Petra E A Huijts; Antoinette Hollestelle; Brunilda Balliu; Jeanine J Houwing-Duistermaat; Caro M Meijers; Jannet C Blom; Bahar Ozturk; Elly M M Krol-Warmerdam; Juul Wijnen; Els M J J Berns; John W M Martens; Caroline Seynaeve; Lambertus A Kiemeney; Henricus F van der Heijden; Rob A E M Tollenaar; Peter Devilee; Christi J van Asperen
Journal:  Eur J Hum Genet       Date:  2013-05-08       Impact factor: 4.246

Review 5.  Genetic architecture of cancer and other complex diseases: lessons learned and future directions.

Authors:  Lucia A Hindorff; Elizabeth M Gillanders; Teri A Manolio
Journal:  Carcinogenesis       Date:  2011-03-31       Impact factor: 4.944

6.  Joint association testing of common and rare genetic variants using hierarchical modeling.

Authors:  Niall J Cardin; Joel A Mefford; John S Witte
Journal:  Genet Epidemiol       Date:  2012-07-16       Impact factor: 2.135

7.  The role of O(6)-methylguanine-DNA methyltransferase polymorphisms in colorectal cancer susceptibility: a meta analysis.

Authors:  Yongchao Lu; Mingfeng Cao; Kejian Gao; Jinjiao Jiang; Xuewen Shi
Journal:  Int J Clin Exp Med       Date:  2015-01-15

8.  Variant allele of CHEK2 is associated with a decreased risk of esophageal cancer lymph node metastasis in a Chinese population.

Authors:  Haiyong Gu; Wanshan Qiu; Ying Wan; Guowen Ding; Weifeng Tang; Chao Liu; Yijun Shi; Yijang Chen; Suocheng Chen
Journal:  Mol Biol Rep       Date:  2011-12-27       Impact factor: 2.316

9.  Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach.

Authors:  Katie M O'Brien; Stephen R Cole; Charles Poole; Jeannette T Bensen; Amy H Herring; Lawrence S Engel; Robert C Millikan
Journal:  Am J Epidemiol       Date:  2013-11-10       Impact factor: 4.897

Review 10.  Use of pathway information in molecular epidemiology.

Authors:  Duncan C Thomas; David V Conti; James Baurley; Frederik Nijhout; Michael Reed; Cornelia M Ulrich
Journal:  Hum Genomics       Date:  2009-10       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.